Doxorubicin Market Revenue to Cross $1,983.40 million by
Doxorubicin Market is expected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022. It is estimated to grow at a CAGR of 6.1% from 2022...
Source: globenewswire.com
Page 4 - Alkylating Agents News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alkylating Agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alkylating Agents Today - Breaking & Trending Today
Branded Generics Market Size Worth $414.99 Billion, Globally, During (2022-2028) at 9.9% CAGR Driven by Oncology Therapeutic Application
/PRNewswire/ -- The Insight Partners published latest research study on "Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Source: prnewswire.com
Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach $976.2 Million by 2026
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...
Source: prnewswire.com
Global Generic Sterile Injectables Market to Surpass US$ 84,856.8 Million by 2030, Says Coherent Market Insights (CMI)
According to Coherent Market Insights, global generic sterile injectables market is estimated to be valued at US$ 38,706.5 million in 2022 and is expected to
Source: einnews.com
Worldwide Systemic Scleroderma Treatment Industry to 2028 - Featuring Bristol-Myers Squibb, GlaxoSmithKline and Corbus Pharmaceuticals Among Others
/PRNewswire/ -- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by Distribution Channel, and by Region...
Source: prnewswire.com